Emapunil is primarily investigated for its potential therapeutic applications in the field of neuropsychiatry and stress-related disorders. It acts as a translocator protein (TSPO) ligand, which is involved in the regulation of neurosteroid synthesis and mitochondrial function in the brain. Research suggests that it may have anxiolytic and neuroprotective properties, making it a candidate for treating conditions such as anxiety, depression, and post-traumatic stress disorder (PTSD). Additionally, its role in modulating inflammation and oxidative stress has sparked interest in its potential use for neurodegenerative diseases like Alzheimer's and Parkinson's. Clinical studies are ongoing to further explore its efficacy and safety in these applications.